Garrido, Greta
Schrand, Brett
Rabasa, Ailem
Levay, Agata
D’Eramo, Francesca
Berezhnoy, Alexey
Modi, Shrey
Gefen, Tal
Marijt, Koen http://orcid.org/0000-0003-4396-0047
Doorduijn, Elien
Dudeja, Vikas
van Hall, Thorbald http://orcid.org/0000-0002-9115-558X
Gilboa, Eli
Article History
Received: 25 December 2018
Accepted: 1 August 2019
First Online: 21 August 2019
Competing interests
: E.G. is a founder and equity holder of Sebastian Biopharma that holds intellectual rights for the neoantigen induction approach described in this study. The remaining authors declare no competing interests.